FI2760882T3 - Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa - Google Patents
Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa Download PDFInfo
- Publication number
- FI2760882T3 FI2760882T3 FIEP12836545.9T FI12836545T FI2760882T3 FI 2760882 T3 FI2760882 T3 FI 2760882T3 FI 12836545 T FI12836545 T FI 12836545T FI 2760882 T3 FI2760882 T3 FI 2760882T3
- Authority
- FI
- Finland
- Prior art keywords
- plant
- influenza
- protein
- seq
- vlp
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims 4
- 241000196324 Embryophyta Species 0.000 claims 20
- 238000000034 method Methods 0.000 claims 18
- 101710154606 Hemagglutinin Proteins 0.000 claims 14
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 14
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 14
- 101710176177 Protein A56 Proteins 0.000 claims 14
- 239000000185 hemagglutinin Substances 0.000 claims 13
- 206010022000 influenza Diseases 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 7
- 125000003729 nucleotide group Chemical group 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 230000009466 transformation Effects 0.000 claims 6
- 108091006146 Channels Proteins 0.000 claims 5
- 102000034573 Channels Human genes 0.000 claims 4
- 241000723607 Comovirus Species 0.000 claims 4
- 208000037797 influenza A Diseases 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 241000702463 Geminiviridae Species 0.000 claims 3
- 208000037798 influenza B Diseases 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 108091029795 Intergenic region Proteins 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 230000002797 proteolythic effect Effects 0.000 claims 2
- 241000710073 Bean yellow mosaic virus Species 0.000 claims 1
- 108010042653 IgA receptor Proteins 0.000 claims 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 230000030279 gene silencing Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 claims 1
- 230000003584 silencer Effects 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16223—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161541780P | 2011-09-30 | 2011-09-30 | |
| PCT/CA2012/050681 WO2013044390A1 (en) | 2011-09-30 | 2012-09-28 | Increasing virus-like particle yield in plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI2760882T3 true FI2760882T3 (fi) | 2023-07-17 |
Family
ID=47994080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP12836545.9T FI2760882T3 (fi) | 2011-09-30 | 2012-09-28 | Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa |
Country Status (27)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11390878B2 (en) | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
| HUE062759T2 (hu) | 2011-09-30 | 2023-12-28 | Medicago Inc | Vírusszerû részecske hozamának növelése növényekben |
| MX376138B (es) * | 2013-03-28 | 2025-03-07 | Medicago Inc | Produccion de particulas similares a virus de influenza en plantas. |
| WO2015103704A1 (en) | 2014-01-10 | 2015-07-16 | Medicago Inc. | Cpmv enhancer elements |
| CN106460005B (zh) * | 2014-03-27 | 2020-01-03 | 莫迪卡戈公司 | 修饰的cpmv增强子元件 |
| JP7423875B6 (ja) * | 2018-03-14 | 2024-03-15 | メディカゴ インコーポレイテッド | 植物発現エンハンサ |
| MX2020013957A (es) * | 2018-06-27 | 2021-03-09 | Medicago Inc | Mutantes de hemaglutinina del virus de la influenza. |
| BR112021017899A2 (pt) * | 2019-03-14 | 2021-12-21 | Medicago Inc | Intensificador de expressão vegetal endógeno |
| WO2021236908A2 (en) * | 2020-05-20 | 2021-11-25 | Biomarin Pharmaceutical Inc. | Use of regulatory proteins for the production of adeno-associated virus |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428147A (en) | 1983-04-15 | 1995-06-27 | Mycogen Plant Science, Inc. | Octopine T-DNA promoters |
| US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4962028A (en) | 1986-07-09 | 1990-10-09 | Dna Plant Technology Corporation | Plant promotors |
| US5232833A (en) | 1988-09-14 | 1993-08-03 | Stressgen Biotechnologies Corporation | Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants |
| US5805417A (en) | 1995-10-13 | 1998-09-08 | Hitachi, Ltd. | Heat dissipation structure in a portable computer including a heat dissipation block extending from a heat dissipation plate through a first circuit board to a CPU on a second circuit board |
| WO2000020557A2 (en) | 1998-10-07 | 2000-04-13 | Boyce Institute For Plant Research At Cornell University | Gemini virus vectors for gene expression in plants |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| RU2164148C1 (ru) * | 2000-08-09 | 2001-03-20 | Петров Рэм Викторович | Вакцина против вируса гриппа и способ ее получения |
| KR20060035596A (ko) * | 2003-05-05 | 2006-04-26 | 보이스 톰슨 인스터튜트 포 플랜트 리서치 | 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포 |
| BRPI0410342A (pt) | 2003-05-05 | 2006-06-20 | Dow Agrosciences Llc | composições imunoprofiláticas e terapêuticas estáveis derivadas de células vegetais transgênicas e processos para produção |
| PL2374892T3 (pl) * | 2005-04-29 | 2018-06-29 | University Of Cape Town | Ekspresja białek wirusa w roślinach |
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| AU2006304640B2 (en) * | 2005-10-18 | 2012-10-11 | Novavax, Inc. | Functional influenza virus like particles (VLPs) |
| WO2007051036A2 (en) * | 2005-10-26 | 2007-05-03 | Protelix, Inc. | Influenza combinatorial antigen vaccine |
| EP1991571A2 (en) | 2006-02-16 | 2008-11-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antiviral agents and vaccines against influenza |
| CA2638760A1 (en) | 2006-03-07 | 2007-09-13 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| WO2008054535A2 (en) | 2006-05-11 | 2008-05-08 | Novavax, Inc. | Novel influenza m2 vaccines |
| EP2029755A1 (en) | 2006-05-22 | 2009-03-04 | Plant Bioscience Limited | Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants |
| KR20090027216A (ko) * | 2006-06-16 | 2009-03-16 | 다우 아그로사이언시즈 엘엘씨 | 조류 인플루엔자 헤마글루티닌의 신규한 ｄｎａ 서열, 벡터, 및 단백질 |
| US8697088B2 (en) | 2007-05-25 | 2014-04-15 | Novavax, Inc. | VLPs derived from cells that do not express a viral matrix or core protein |
| CN104962579A (zh) | 2007-06-15 | 2015-10-07 | 麦迪卡格公司 | 修饰植物中的糖蛋白产生 |
| CA2615372A1 (en) * | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| EP2238253B1 (en) | 2007-11-27 | 2012-09-12 | Medicago Inc. | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| GB0800272D0 (en) | 2008-01-08 | 2008-02-13 | Plant Bioscience Ltd | Protein expression systems |
| KR101956910B1 (ko) | 2008-01-21 | 2019-03-12 | 메디카고 인코포레이티드 | 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ) |
| WO2010003235A1 (en) | 2008-07-08 | 2010-01-14 | Medicago Inc. | Soluble recombinant influenza antigens |
| MY161965A (en) * | 2008-07-18 | 2017-05-15 | Medicago Inc | New influenza virus immunizing epitope |
| AU2009285667B2 (en) | 2008-08-27 | 2015-05-28 | Arizona Board Of Regents For And On Behalf Of Arizona State University | A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants |
| EP3009145A1 (en) | 2009-03-30 | 2016-04-20 | Mount Sinai School of Medicine of New York University | Influenza virus vaccines and uses thereof |
| IN2012DN00650A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2009-06-24 | 2015-06-12 | Medicago Inc | |
| FR2947875B1 (fr) | 2009-07-10 | 2011-07-08 | Raymond A & Cie | Dispositif de fixation a elements de fixation multiples dont l'un est flottant |
| WO2011011390A1 (en) | 2009-07-20 | 2011-01-27 | Novavax, Inc. | Purified recombinant influenza virus ha proteins |
| DK2480560T3 (en) | 2009-09-22 | 2018-04-16 | Medicago Inc | PROCEDURE FOR THE PREPARATION OF PLANT DERIVATIVE PROTEINS |
| EP2536428B1 (en) | 2010-02-18 | 2018-12-05 | Technovax, Inc. | Universal virus-like particle (vlp) influenza vaccines |
| US10226527B2 (en) | 2010-10-04 | 2019-03-12 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| PL220281B1 (pl) | 2011-09-23 | 2015-09-30 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA |
| HUE062759T2 (hu) | 2011-09-30 | 2023-12-28 | Medicago Inc | Vírusszerû részecske hozamának növelése növényekben |
| US11390878B2 (en) * | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
| JP6205359B2 (ja) | 2012-07-23 | 2017-09-27 | 有限会社生物資源研究所 | ワクチン |
| MX376138B (es) | 2013-03-28 | 2025-03-07 | Medicago Inc | Produccion de particulas similares a virus de influenza en plantas. |
-
2012
- 2012-09-28 HU HUE12836545A patent/HUE062759T2/hu unknown
- 2012-09-28 NZ NZ622731A patent/NZ622731A/en not_active IP Right Cessation
- 2012-09-28 SG SG11201400712VA patent/SG11201400712VA/en unknown
- 2012-09-28 DK DK12836545.9T patent/DK2760882T5/da active
- 2012-09-28 CN CN202310130025.2A patent/CN116218900A/zh active Pending
- 2012-09-28 WO PCT/CA2012/050681 patent/WO2013044390A1/en not_active Application Discontinuation
- 2012-09-28 SI SI201232036T patent/SI2760882T1/sl unknown
- 2012-09-28 ES ES12836545T patent/ES2951259T3/es active Active
- 2012-09-28 PH PH1/2014/500640A patent/PH12014500640A1/en unknown
- 2012-09-28 MY MYPI2014700716A patent/MY184072A/en unknown
- 2012-09-28 JP JP2014532198A patent/JP6248040B2/ja active Active
- 2012-09-28 AU AU2012315421A patent/AU2012315421C1/en active Active
- 2012-09-28 CN CN201280047819.2A patent/CN103930435A/zh active Pending
- 2012-09-28 PL PL12836545.9T patent/PL2760882T3/pl unknown
- 2012-09-28 HR HRP20230695TT patent/HRP20230695T1/hr unknown
- 2012-09-28 BR BR112014007474A patent/BR112014007474A2/pt not_active Application Discontinuation
- 2012-09-28 RU RU2014116371A patent/RU2682752C2/ru active
- 2012-09-28 IN IN3077CHN2014 patent/IN2014CN03077A/en unknown
- 2012-09-28 EP EP12836545.9A patent/EP2760882B1/en active Active
- 2012-09-28 PT PT128365459T patent/PT2760882T/pt unknown
- 2012-09-28 TW TW101135891A patent/TWI700368B/zh not_active IP Right Cessation
- 2012-09-28 FI FIEP12836545.9T patent/FI2760882T3/fi active
- 2012-09-28 US US14/347,804 patent/US11155581B2/en active Active
- 2012-09-28 KR KR1020147011886A patent/KR101974017B1/ko active Active
- 2012-09-28 SG SG10201708052XA patent/SG10201708052XA/en unknown
- 2012-09-28 MX MX2014003776A patent/MX358883B/es active IP Right Grant
- 2012-09-28 CA CA2850407A patent/CA2850407C/en active Active
- 2012-09-28 EP EP19205918.6A patent/EP3626733B1/en active Active
-
2014
- 2014-03-19 IL IL231587A patent/IL231587B/en active IP Right Grant
- 2014-03-28 MX MX2018006627A patent/MX2018006627A/es unknown
- 2014-04-29 ZA ZA2014/03059A patent/ZA201403059B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI2760882T3 (fi) | Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa | |
| JP2016052331A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| RU2012103038A (ru) | Введение днк в растительные клетки | |
| RU2015146097A (ru) | Получение вирусоподобных частиц вируса гриппа в растениях | |
| IL253187B (en) | Novel multivalent nanoparticle-based vaccines | |
| RU2013154698A (ru) | Получение вирусоподобной частицы вируса бешенства в растениях | |
| WO2012083445A8 (en) | Virus like particle production in plants | |
| RU2011105073A (ru) | Вирусоподобные частицы (впч) вируса гриппа, содержащие гемагглютинин | |
| MX2018004265A (es) | Metodo para producir plantas de genoma modificado a partir de protoplastos de planta a alta eficiencia. | |
| RU2015144014A (ru) | Конститутивные промоторы сои | |
| JP2016516415A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JP2015517304A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Rota et al. | Molecular virology of the henipaviruses | |
| US11884929B2 (en) | CPMV enhancer elements | |
| JP2017513467A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| RU2015129061A (ru) | Регулярные элементы растений и их применение | |
| JP6788582B2 (ja) | 植物におけるタンパク質生産の改変 | |
| CN104498631A (zh) | 致产蛋异常重要病毒多重pcr检测引物及方法 | |
| RU2012117014A (ru) | Способ получения рекомбинантного капсидного белка вируса гепатита е. рекомбинантная вакцина для профилактики вирусного гепатита е. | |
| RU2008141401A (ru) | Способ повышения эффективности вирусных систем продукции рекомбинантных белков в растениях | |
| PUA et al. | Plant-based Transient Expression of Neuraminidase of Malaysian Avian Influenza | |
| RU2008139004A (ru) | Ген вакцинного искусственного белка, продуцирующий в растениях рекомбинантную мультиэпитопную вакцину на базе гемагглютинина вируса гриппа птиц | |
| WO2009006420A3 (en) | Vaccine production for pathogenic bird viral diseases | |
| Pakbaz et al. | A method for Evaluation of RNA Silencing Suppression Activity in Plants Using two Proteins of Grapevine Fanleaf Virus (GFLV) | |
| RU2023100519A (ru) | Способы и композиции для увеличения урожайности низкорослых растений путем манипуляции метаболизма гиббереллина |